Publications by authors named "Pearl Wang"

Claim this Profile
M
Matching-adjusted indirect comparison of lisocabtagene maraleucel versus axicabtagene ciloleucel for second-line treatment of patients with early relapsed or refractory large B-cell lymphoma.
Jeremy S Abramson, Manali Kamdar, Fei Fei Liu, Alessandro Crotta, Alessandro Previtali, Pearl Wang

Leuk Lymphoma· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matching-adjusted indirect comparison of efficacy and safety of lisocabtagene maraleucel and mosunetuzumab for the treatment of third-line or later relapsed or refractory follicular lymphoma.
Loretta J Nastoupil, Ashley Bonner, Pearl Wang, Lamees Almuallem, Jigar Desai

Exp Hematol Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining a core set of research and development priorities for virtual care in the post-pandemic environment: a call to action.
Kavisha Shah, Nicki Newton, Emma Charlston, Miranda Shaw, Jagdev Singh, Pearl Wang

Med J Aust· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health care resource utilization in 3L + patients with chronic phase chronic myeloid leukemia receiving asciminib or bosutinib.
Jorge E Cortes, Delphine Rea, Michael J Mauro, Diana Tran, Pearl Wang

J Med Econ· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter in reply: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus.
Ian N Bruce, Sarowar Golam, Jason Steenkamp, Pearl Wang, Evelyn Worthington

J Comp Eff Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus.
Ian N Bruce, Sarowar Golam, Jason Steenkamp, Pearl Wang, Evelyn Worthington

J Comp Eff Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis